Assessment of Liver Stiffness in non- obese patient with type 2 diabetes
Not Applicable
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/06/054199
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with T2DM (up to 15 years Duration)
2. Age 25 to 60 years
3. BMI < 25 kg/m²
4. Gender- Both
5. USG finding showing definitive fatty liver
Exclusion Criteria
1. Chronic significant alcohol intake ( > 20 gm/day)
2. BMI > 25 kg/m²
3. Congestive heart disease
4. Positive hepatitis B or hepatitis C, secondary causes of fatty liver (eg, consumption of
amiodarone and tamoxifen) and congestive hepatopathy.
5. Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy,
major systemic illness etc.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To asses hepatic fat (by CAP) and hepatic fibrosis (by kPA) in Non obese patient with T2DM.Timepoint: 6 months
- Secondary Outcome Measures
Name Time Method To assess Liver fibrosis in non-obese type 2 diabetes patientsTimepoint: 6 months